Soligenix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Soligenix and other ETFs, options, and stocks.About SNGX
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments.
CEOChristopher J. Schaber
CEOChristopher J. Schaber
Employees16
Employees16
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1987
Founded1987
Employees16
Employees16
SNGX Key Statistics
Market cap13.97M
Market cap13.97M
Price-Earnings ratio-0.37
Price-Earnings ratio-0.37
Dividend yield—
Dividend yield—
Average volume589.11K
Average volume589.11K
High today$1.42
High today$1.42
Low today$1.34
Low today$1.34
Open price$1.38
Open price$1.38
Volume136.43K
Volume136.43K
52 Week high$6.23
52 Week high$6.23
52 Week low$1.09
52 Week low$1.09
Stock Snapshot
As of today, Soligenix(SNGX) shares are valued at $1.39. The company's market cap stands at 13.97M, with a P/E ratio of -0.37.
On 2026-01-02, Soligenix(SNGX) stock traded between a low of $1.34 and a high of $1.42. Shares are currently priced at $1.39, which is +3.4% above the low and -2.5% below the high.
Soligenix(SNGX) shares are trading with a volume of 136.43K, against a daily average of 589.11K.
During the past year, Soligenix(SNGX) stock moved between $1.09 at its lowest and $6.23 at its peak.
During the past year, Soligenix(SNGX) stock moved between $1.09 at its lowest and $6.23 at its peak.
People also own
Based on the portfolios of people who own SNGX. This list is generated using Robinhood data, and it’s not a recommendation.